Of note, cleaved-GSDMD serves as a key executor of pyroptotic cell death that plays a pathogenic role in MASLD development and progression in both humans and mice, and targeting GSDMD markedly alleviated steatohepatitis in mouse models of MASH [9–11]. The gene discussed is GSDMD; the disease is metabolic dysfunction-associated steatotic liver disease.